Влияние полиморфизма гена β1-адренорецептора Arg389Gly на снижение ЧСС у пациентов с ХСН на фоне лечения метопрололом CR/XL

1. Mancinelli L, Cronin M, Sadee W. Pharmacogenomics: the promise of personalized medicine. AAPS PharmSci 2000. 2:E4

2. Roses A.D. Pharmacogenetics and the practice of medicine. Nature 2000; 405:857-65

3. Stephen B. Liggett BEST Substudy: Beta1-adrenergic Receptor Polymorphism and the Prediction of Clinical Response in the beta-Blocker Evaluation of Survival Trial Presented at the 8th Annual Scientific Meeting of the Heart Failure Society of America; September 12-15, 2004; Toronto, Ontario, Canada.

4. White HL, de Boer RA, Maqbool A et al. An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a Merit-HF sub-study. Eur J heart fail. 2003 Aug;5(4):463.